糖尿病眼疾患デバイス市場：製品タイプ、エンドユーザー、適応症、技術別-2025-2030年の世界予測

糖尿病眼疾患デバイス市場は、2023年に173億8,000万米ドルと評価され、2024年には189億2,000万米ドルに達すると予測され、CAGR 9.56％で成長し、2030年には329億5,000万米ドルに達すると予測されています。

糖尿病眼疾患デバイスの対象範囲には、糖尿病網膜症、糖尿病黄斑浮腫、白内障、緑内障など、糖尿病に起因する眼関連の合併症を診断、監視、治療するために設計されたさまざまな医療機器や技術が含まれます。これらの機器は、糖尿病患者の視力障害や失明を予防する上で極めて重要であり、ヘルスケアシステムにおける必需品となっています。主な用途には、光干渉断層計のような画像システム、スクリーニングツール、レーザー治療、眼内レンズなどがあります。最終用途の範囲には、糖尿病患者の目の健康を積極的に管理している病院、専門眼科クリニック、研究機関が含まれます。市場成長は、世界の糖尿病有病率の上昇、糖尿病合併症に対する意識の高まり、画像診断や低侵襲治療ソリューションの技術進歩の影響を大きく受けています。急増する糖尿病人口と満たされていないヘルスケアニーズにより、アジア太平洋の市場拡大には機会があふれています。治療法としては、早期発見・治療能力を高める遠隔医療プラットフォームやAI主導の診断ツールへの投資が挙げられます。しかし、先進的な機器の高額なコスト、厳しい規制環境、地方における限られたアクセシビリティなどの制約が市場拡大の課題となっています。継続的な研究開発は、個別化医療アプローチ、ロボット支援手術ツール、強化された画像診断モダリティなどのイノベーションを探求する上で不可欠であり、これらは患者の転帰に革命をもたらし、市場のプレゼンスを拡大する可能性があります。市場はダイナミックであり、急速な技術進化と主要プレーヤー間の競争的提携が特徴です。新興経済諸国では、費用対効果の高いポータブル機器の開発と流通網の拡大に注力する企業が大きな躍進を遂げると思われます。さらに、非営利団体や政府の医療プログラムとの提携を促進することで、アクセシビリティと市場浸透を強化できる可能性があります。全体として有望ではあるが、糖尿病性眼疾患の全人的管理という急成長の機会を十分に生かすためには、糖尿病眼疾患デバイス市場の課題を慎重に乗り越える必要があります。

市場力学：急速に進化する糖尿病眼疾患デバイス市場の主要市場インサイトを公開

糖尿病眼疾患デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病眼科医療における遠隔医療およびデジタルヘルスソリューションの採用の増加
  • 革新と市場拡大のための業界主要企業間の連携
  • 糖尿病網膜症治療のための研究開発投資の増加
  • 新興市場におけるヘルスケアインフラの拡大による治療へのアクセスの増加
• 市場抑制要因
  • 高い資本コストと糖尿病眼疾患デバイスの製品リコール
• 市場機会
  • 正確な糖尿病性眼疾患診断のための最先端AI駆動型プラットフォーム
  • 十分なサービスを受けていない糖尿病患者のための手頃な価格で持ち運び可能なスクリーニングツール
  • 糖尿病網膜症治療のための非侵襲的治療デバイスの開発
• 市場の課題
  • 熟練した専門家の不足とデバイスの技術的限界

ポーターの5つの力：糖尿病眼疾患デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：糖尿病眼疾患デバイス市場における外部からの影響の把握

外部マクロ環境要因は、糖尿病眼疾患デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析糖尿病眼疾患デバイス市場における競合情勢の把握

糖尿病眼疾患デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス糖尿病眼疾患デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、糖尿病眼疾患デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨糖尿病眼疾患デバイス市場における成功への道筋を描く

糖尿病眼疾患デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病眼科ケアにおける遠隔医療とデジタルヘルスソリューションの導入増加
    • 革新と市場拡大を目指した業界主要企業間のコラボレーション
    • 糖尿病網膜症治療の研究開発への投資増加
    • 新興市場におけるヘルスケアインフラの拡大により医療へのアクセスが向上
  • 抑制要因
    • 糖尿病眼疾患デバイスの高額な資本コストと製品リコール
  • 機会
    • 糖尿病性眼疾患の正確な診断のための最先端のAI駆動型プラットフォーム
    • 十分なサービスを受けていない糖尿病患者のための、手頃な価格で持ち運び可能なスクリーニングツール
    • 糖尿病網膜症治療のための非侵襲性治療機器の開発
  • 課題
    • 熟練した専門家の不足とデバイスの技術的限界
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 糖尿病眼疾患デバイス市場：製品タイプ別

• 診断装置
  • フルオレセイン蛍光眼底造影検査
  • 眼底カメラ
  • 光干渉断層撮影（OCT）スキャナ
• 治療機器
  • 眼内レンズ（IOL）
  • レーザーシステム
    • 光凝固レーザー
    • 光破壊レーザー
  • 硝子体切除装置

第7章 糖尿病眼疾患デバイス市場：エンドユーザー別

• 外来手術センター
• 病院
• 眼科クリニック

第8章 糖尿病眼疾患デバイス市場適応症別

• 糖尿病黄斑浮腫（DME）
  • 拡散DME
  • 焦点DME
• 糖尿病網膜症
  • 非増殖性糖尿病網膜症
  • 増殖性糖尿病網膜症

第9章 糖尿病眼疾患デバイス市場：技術別

• 硝子体内注射
• レーザー治療
• 硝子体切除術

第10章 南北アメリカの糖尿病眼疾患デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の糖尿病眼疾患デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの糖尿病眼疾患デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Abbott Laboratories
• 2. Alcon Inc.
• 3. Allergan plc
• 4. Bayer AG
• 5. BD (Becton, Dickinson and Company)
• 6. Carl Zeiss AG
• 7. Clearside Biomedical, Inc.
• 8. F. Hoffmann-La Roche Ltd
• 9. Genentech, Inc.
• 10. GlaxoSmithKline plc
• 11. Iveric Bio, Inc.
• 12. Novartis AG
• 13. Ocular Therapeutix, Inc.
• 14. Optos plc
• 15. Pfizer Inc.
• 16. Regeneron Pharmaceuticals, Inc.
• 17. Sanofi S.A.
• 18. Santen Pharmaceutical Co., Ltd.
• 19. Topcon Corporation
• 20. Vitreoretinal Technologies, Inc.

LIST OF FIGURES

• FIGURE 1. DIABETIC EYE DISEASE DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. DIABETIC EYE DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. DIABETIC EYE DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIABETIC EYE DISEASE DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FLUORESCEIN ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INTRAOCULAR LENSES (IOLS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PHOTOCOAGULATION LASERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PHOTODISRUPTION LASERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY VITRECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIFFUSE DME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY FOCAL DME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY NON-PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INTRAVITREAL INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY VITRECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 69. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 70. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 73. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 74. CANADA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 82. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 104. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 106. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 115. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 117. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 120. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 121. CHINA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 125. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 126. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 129. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 130. INDIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 142. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 147. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 157. MALAYSIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 161. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 165. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 166. PHILIPPINES DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 169. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 170. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 173. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 174. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 175. SINGAPORE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 180. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 183. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 184. SOUTH KOREA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 189. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 191. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 192. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 193. TAIWAN DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 197. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 198. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 199. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 200. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 201. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 202. THAILAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 205. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 206. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 207. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 209. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 210. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 211. VIETNAM DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. EUROPE, MIDDLE EAST & AFRICA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 222. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 223. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 225. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 226. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 228. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 229. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 230. DENMARK DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 234. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 235. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 236. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 237. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 238. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 239. EGYPT DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 240. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 241. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 242. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 243. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 244. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 245. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 246. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 247. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 248. FINLAND DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 249. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 250. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 251. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 252. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 253. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 255. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 256. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 257. FRANCE DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 258. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 259. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 260. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 261. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 262. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 263. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 264. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 265. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 266. GERMANY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 268. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 269. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 270. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 271. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 272. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 273. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 274. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 275. ISRAEL DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 276. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 277. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 278. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 279. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 280. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 281. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 282. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 283. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 284. ITALY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 285. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 286. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 287. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 288. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 289. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 290. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 291. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 292. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 293. NETHERLANDS DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 294. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 295. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 296. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 297. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 298. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 299. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 300. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA (DME), 2018-2030 (USD MILLION)
• TABLE 301. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2030 (USD MILLION)
• TABLE 302. NIGERIA DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 303. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 304. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2030 (USD MILLION)
• TABLE 305. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 306. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY LASER SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 307. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 308. NORWAY DIABETIC EYE DISEASE DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)

TABLE

The Diabetic Eye Disease Devices Market was valued at USD 17.38 billion in 2023, expected to reach USD 18.92 billion in 2024, and is projected to grow at a CAGR of 9.56%, to USD 32.95 billion by 2030.

The scope of diabetic eye disease devices encompasses a range of medical equipment and technologies designed to diagnose, monitor, and treat eye-related complications arising from diabetes, including diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. These devices are crucial in preventing vision impairment and blindness in diabetic patients, making them a necessity within the healthcare system. Primary applications include imaging systems like optical coherence tomography, screening tools, laser therapies, and intraocular lenses. The end-use scope covers hospitals, specialized eye clinics, and research institutes actively managing diabetic eye health. Market growth is significantly influenced by the rising prevalence of diabetes globally, increasing awareness about diabetic complications, and technological advancements in diagnostic imaging and minimally invasive treatment solutions. Opportunities abound in expanding markets in Asia-Pacific due to burgeoning diabetic populations and unmet healthcare needs. Recommendations include investing in telemedicine platforms and AI-driven diagnostic tools that can enhance early detection and treatment capabilities. However, limitations such as high costs of advanced devices, stringent regulatory environments, and limited accessibility in rural regions challenge market expansion. Continuous R&D is essential in exploring innovations like personalized medicine approaches, robotic-assisted surgical tools, and enhanced imaging modalities, which could revolutionize patient outcomes and expand market presence. The market is dynamic, characterized by rapid technological evolution and competitive collaborations among key players. Organizations focusing on developing cost-effective, portable devices and expanding distribution networks in emerging economies stand to make significant strides. Furthermore, fostering partnerships with non-profits and governmental health programs could bolster accessibility and market penetration. Overall, while promising, the diabetic eye disease devices market requires careful navigation of its challenges to fully capitalize on the burgeoning opportunities for holistic management of diabetic eye conditions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetic Eye Disease Devices Market

The Diabetic Eye Disease Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing adoption of telemedicine and digital health solutions for diabetic eye care
  • Collaborations between key industry players to innovate and expand market reach
  • Growing investments in research and development for diabetic retinopathy treatments
  • Expansion of healthcare infrastructure in emerging markets increasing access to care
• Market Restraints
  • High capital costs and product recalls of diabetic eye disease devices
• Market Opportunities
  • Cutting-edge AI-driven platforms for accurate diabetic eye disease diagnostics
  • Affordable and portable screening tools for underserved diabetic populations
  • Development of non-invasive therapeutic devices for diabetic retinopathy treatment
• Market Challenges
  • Limited availability of skilled professionals and technical limitations with devices

Porter's Five Forces: A Strategic Tool for Navigating the Diabetic Eye Disease Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetic Eye Disease Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetic Eye Disease Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetic Eye Disease Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetic Eye Disease Devices Market

A detailed market share analysis in the Diabetic Eye Disease Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetic Eye Disease Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetic Eye Disease Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetic Eye Disease Devices Market

A strategic analysis of the Diabetic Eye Disease Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetic Eye Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alcon Inc., Allergan plc, Bayer AG, BD (Becton, Dickinson and Company), Carl Zeiss AG, Clearside Biomedical, Inc., F. Hoffmann-La Roche Ltd, Genentech, Inc., GlaxoSmithKline plc, Iveric Bio, Inc., Novartis AG, Ocular Therapeutix, Inc., Optos plc, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Santen Pharmaceutical Co., Ltd., Topcon Corporation, and Vitreoretinal Technologies, Inc..

Market Segmentation & Coverage

This research report categorizes the Diabetic Eye Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Diagnostic Devices and Treatment Devices. The Diagnostic Devices is further studied across Fluorescein Angiography, Fundus Cameras, and Optical Coherence Tomography (OCT) Scanners. The Treatment Devices is further studied across Intraocular Lenses (IOLs), Laser Systems, and Vitrectomy Devices. The Laser Systems is further studied across Photocoagulation Lasers and Photodisruption Lasers.
• Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Ophthalmic Clinics.
• Based on Indication, market is studied across Diabetic Macular Edema (DME) and Diabetic Retinopathy. The Diabetic Macular Edema (DME) is further studied across Diffuse DME and Focal DME. The Diabetic Retinopathy is further studied across Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
• Based on Technology, market is studied across Intravitreal Injections, Laser Therapy, and Vitrectomy.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing adoption of telemedicine and digital health solutions for diabetic eye care
    • 5.1.1.2. Collaborations between key industry players to innovate and expand market reach
    • 5.1.1.3. Growing investments in research and development for diabetic retinopathy treatments
    • 5.1.1.4. Expansion of healthcare infrastructure in emerging markets increasing access to care
  • 5.1.2. Restraints
    • 5.1.2.1. High capital costs and product recalls of diabetic eye disease devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Cutting-edge AI-driven platforms for accurate diabetic eye disease diagnostics
    • 5.1.3.2. Affordable and portable screening tools for underserved diabetic populations
    • 5.1.3.3. Development of non-invasive therapeutic devices for diabetic retinopathy treatment
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of skilled professionals and technical limitations with devices
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Diabetic Eye Disease Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Diagnostic Devices
  • 6.2.1. Fluorescein Angiography
  • 6.2.2. Fundus Cameras
  • 6.2.3. Optical Coherence Tomography (OCT) Scanners
• 6.3. Treatment Devices
  • 6.3.1. Intraocular Lenses (IOLs)
  • 6.3.2. Laser Systems
    • 6.3.2.1. Photocoagulation Lasers
    • 6.3.2.2. Photodisruption Lasers
  • 6.3.3. Vitrectomy Devices

7. Diabetic Eye Disease Devices Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals
• 7.4. Ophthalmic Clinics

8. Diabetic Eye Disease Devices Market, by Indication

• 8.1. Introduction
• 8.2. Diabetic Macular Edema (DME)
  • 8.2.1. Diffuse DME
  • 8.2.2. Focal DME
• 8.3. Diabetic Retinopathy
  • 8.3.1. Non-Proliferative Diabetic Retinopathy
  • 8.3.2. Proliferative Diabetic Retinopathy

9. Diabetic Eye Disease Devices Market, by Technology

• 9.1. Introduction
• 9.2. Intravitreal Injections
• 9.3. Laser Therapy
• 9.4. Vitrectomy

10. Americas Diabetic Eye Disease Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Diabetic Eye Disease Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Diabetic Eye Disease Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Alcon Inc.
• 3. Allergan plc
• 4. Bayer AG
• 5. BD (Becton, Dickinson and Company)
• 6. Carl Zeiss AG
• 7. Clearside Biomedical, Inc.
• 8. F. Hoffmann-La Roche Ltd
• 9. Genentech, Inc.
• 10. GlaxoSmithKline plc
• 11. Iveric Bio, Inc.
• 12. Novartis AG
• 13. Ocular Therapeutix, Inc.
• 14. Optos plc
• 15. Pfizer Inc.
• 16. Regeneron Pharmaceuticals, Inc.
• 17. Sanofi S.A.
• 18. Santen Pharmaceutical Co., Ltd.
• 19. Topcon Corporation
• 20. Vitreoretinal Technologies, Inc.